Summary
Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s product categories include ultrasound healing therapy, human biologics, antimicrobial protection, and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua BioMedical develops and manufactures electron-beam cross-linked sheet gels for manufacturer of medical devices, cosmeceuticals, and other commercial product applications. The company’s customer service professionals assist with order placement, product training, and reimbursement. Alliqua BioMedical is headquartered in Yardley, Pennsylvania, the US.
Alliqua BioMedical Inc (ALQA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alliqua Enters Into Distribution Agreement With Sorbion 11
Licensing Agreements 11
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 11
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 12
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 13
Alliqua Enters Into Licensing Agreement With Noble Biomaterials 14
Equity Offering 15
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 15
Alliqua Completes Private Placement Of Shares For US$15 Million 16
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 17
Alliqua Completes Private Placement Of Shares For US$0.4 Million 18
Alliqua BioMedical Inc - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results 23
Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 24
Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 25
Nov 04, 2016: Alliqua BioMedical Reports Third Quarter and Nine-Months Fiscal Year 2016 Financial Results 28
Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue 30
Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for November 4th 31
Aug 09, 2016: Alliqua BioMedical Reports Second Quarter and Six Months Fiscal Year 2016 Financial Results 32
Jul 07, 2016: Alliqua BioMedical Announces Preliminary Second Quarter of Fiscal Year 2016 Revenue 34
May 10, 2016: Alliqua BioMedical Reports First Quarter Financial Results 35
Feb 23, 2016: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2015 Financial Results 37
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alliqua Enters Into Distribution Agreement With Sorbion 11
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 11
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 12
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 13
Alliqua Enters Into Licensing Agreement With Noble Biomaterials 14
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 15
Alliqua Completes Private Placement Of Shares For US$15 Million 16
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 17
Alliqua Completes Private Placement Of Shares For US$0.4 Million 18
Alliqua BioMedical Inc, Key Competitors 20
Alliqua BioMedical Inc, Key Employees 21
Alliqua BioMedical Inc, Subsidiaries 22
List of Figures
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Medical Devices Deals, 2011 to YTD 2017 9
